Patent 7514568 was granted and assigned to Smithkline Beecham Limited on April, 2009 by the United States Patent and Trademark Office.
The invention relates to new methods of preparing substituted benzimidazole compounds, such as 2-bromo-5,6-dichlorobenzimidazole, which are useful in the preparation of compounds having antiviral activity.